Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer (Q35758280)
scientific article published on 16 May 2005
Language:
(P31) (Q13442814)
(P50) (Q104437536)
(Q99633273)
(P304) 3923-3931
(P407) (Q1860)
(P433) 17
(P478) 23
(P577) Monday, May 16, 2005
(P1433) (Q400292)
(P1476) "Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer" (language: en)
(P2093) William Kevin Kelly
Lee M Krug
Judy H Chiao
Mark Heaney
Tracy Curley
Barbara MacGregore-Cortelli
William Tong
J Paul Secrist
Lawrence Schwartz
Stacy Richardson
Elaina Chu
Semra Olgac
Paul A Marks
Victoria M Richon
(P2860) (Q40587596)
(Q33356908)
(Q35044538)
(Q40694067)
(Q24535620)
(Q24791823)
(Q34126908)
(Q29616553)
(Q24531167)
(Q38299556)
(Q33773306)
(Q41251712)
(Q29620070)
(Q37919763)
(Q52548831)
(Q43802258)
(Q43666601)
(Q80489191)
other details
description scientific article published on 16 May 2005

External Links